Evidence map›Paper›PMID 30972003›Full record

ArticleFrontiers in neurology2019

Changes in Plasma von Willebrand Factor and Cellular Fibronectin in MRI-Defined Traumatic Microvascular Injury.

Danielle K Sandsmark, Tanya Bogoslovsky, Bao-Xi Qu, Margalit Haber, Martin R Cota, Cora Davis, John A Butman, Lawrence L Latour, Ramon Diaz-Arrastia

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Blood Biomarkers in Brain Injury Medicine.Current physical medicine and rehabilitation reports · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Danielle K SandsmarkDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, United States.
Tanya BogoslovskyDivision of Clinical Neurosciences, Turku University Hospital, University of Turku, Turku, Finland.
Bao-Xi QuCenter for Neuroscience and Regenerative Medicine, Bethesda, MD, United States.
Margalit HaberDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, United States.
Martin R CotaCenter for Neuroscience and Regenerative Medicine, Bethesda, MD, United States.
Cora DavisDepartment of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
John A ButmanCenter for Neuroscience and Regenerative Medicine, Bethesda, MD, United States.
Lawrence L LatourCenter for Neuroscience and Regenerative Medicine, Bethesda, MD, United States.
Ramon Diaz-ArrastiaDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, United States.
University of Pennsylvania · USCenter for Neuroscience and Regenerative Medicine · USNational Institute of Neurological Disorders and Stroke · USTurku University Hospital · FIUniformed Services University of the Health Sciences · US

Funding

Eval, Pathogenesis, Outcome of Subjects with or Suspected Traumatic Brain InjuryZIANS003120 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI LATOUR, LAWRENCE · 2010 to 2025
$16.5M
Natural History of Traumatic Microvascular InjuryK23NS104239 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI SANDSMARK, DANIELLE KAYE · 2017 to 2021
$929k
NINDS NIH HHS K23 NS104239
6 · The paper itself

Abstract

The neuropathology of traumatic brain injury (TB) is diverse, including primary injury to neurons, axons, glial cells, vascular structures, and secondary processes, such as edema and inflammation that vary between individual patients. Traumatic microvascular injury is an important endophenotype of TBI-related injury. We studied patients who sustained a TBI requiring ER evaluation and had an MRI performed within 48 h of injury. We classified patients into 3 groups based on their MRI findings: (1) those that had evidence of traumatic microvascular injury on susceptibility or diffusion weighted MRI sequences without frank hemorrhage [Traumatic Vascular Injury (TVI) group; 20 subjects]. (2) those who had evidence of intraparenchymal, subdural, epidural, or subarachnoid hemorrhage [Traumatic Hemorrhage (TH) group; 26 subjects], and (3) those who had no traumatic injuries detected by MRI [MRI-negative group; 30 subjects]. We then measured plasma protein biomarkers of vascular injury [von Willebrand Factor (vWF) or cellular fibronectin (cFn)] and axonal injury (phosphorylated neurofilament heavy chain; pNF-H). We found that the TVI group was characterized by decreased expression of plasma vWF (

Indexed as

biomarkersMRITBItraumavascular

Identifiers

PMID30972003
PMCPMC6445052
OpenAlexW2924336337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.